Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 717 (USA) (Dr. Reyes)
· consented 2013-01-22
Adverse events
6
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
mild
assessed
2026-08-18
Mild INSOMNIA — outcome: RECOVERED/RESOLVED; onset 2013-04-17 (study day 86.0); relationship: POSSIBLE
mild
assessed
2026-08-18
Mild PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-02-03 (study day 13.0); relationship: PROBABLE
moderate
assessed
2026-08-18
Moderate PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-02-03 (study day 13.0); relationship: PROBABLE
severe
assessed
2026-08-18
Severe RASH — outcome: RECOVERED/RESOLVED; onset 2013-04-25 (study day 94.0); relationship: REMOTE
mild
assessed
2026-08-18
Mild SKIN IRRITATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-01-26 (study day 5.0); relationship: PROBABLE
moderate
assessed
2026-08-18
Moderate SKIN IRRITATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-01-26 (study day 5.0); relationship: PROBABLE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.